MYC and lymphoma: To validate Arrdc3 as a hit from our screen, we used CRISPR/Cas9 and an sgRNA targeting Arrdc3 to generate Arrdc3 knockout (Arrdc3KO) cells in three well-characterised Eμ-Myc mouse lymphoma cell lines—AH15A, AF47A, and 560 [31].